Cinemark Holdings, Inc. CNK
We take great care to ensure that the data presented and summarized in this overview for Cinemark Holdings, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CNK
View all-
Black Rock Inc. New York, NY16.3MShares$469 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.3MShares$354 Million0.01% of portfolio
-
Orbis Allan Gray LTD Hamilton, D010.1MShares$292 Million1.82% of portfolio
-
Wellington Management Group LLP Boston, MA9.35MShares$269 Million0.05% of portfolio
-
Candlestick Capital Management LP Greenwich, CT5.49MShares$158 Million3.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.25MShares$122 Million0.17% of portfolio
-
State Street Corp Boston, MA4.09MShares$118 Million0.0% of portfolio
-
Barclays PLC London, X03.71MShares$107 Million0.03% of portfolio
-
Steadfast Capital Management LP New York, NY3.68MShares$106 Million2.72% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.03MShares$87.4 Million0.02% of portfolio
Latest Institutional Activity in CNK
Top Purchases
Top Sells
About CNK
Cinemark Holdings, Inc., together with its subsidiaries, engages in the motion picture exhibition business. As of June 30, 2022, it operated 522 theatres with 5,868 screens in the United States, and South and Central America. The company was founded in 1984 and is headquartered in Plano, Texas.
Insider Transactions at CNK
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 13
2025
|
Steve Rosenberg |
BUY
Grant, award, or other acquisition
|
Direct |
4,200
+4.23%
|
-
|
Jun 13
2025
|
Raymond W Syufy |
BUY
Grant, award, or other acquisition
|
Direct |
4,200
+6.35%
|
-
|
Jun 13
2025
|
Carlos M Sepulveda |
BUY
Grant, award, or other acquisition
|
Direct |
4,200
+4.87%
|
-
|
Jun 13
2025
|
Ximena G Humrichouse |
BUY
Grant, award, or other acquisition
|
Direct |
4,200
+6.86%
|
-
|
Jun 13
2025
|
Nancy S. Loewe |
BUY
Grant, award, or other acquisition
|
Direct |
4,200
+7.81%
|
-
|
Jun 13
2025
|
Benjamin D Chereskin |
BUY
Grant, award, or other acquisition
|
Direct |
4,200
+3.93%
|
-
|
Jun 13
2025
|
Mark Zoradi |
BUY
Grant, award, or other acquisition
|
Direct |
4,200
+0.93%
|
-
|
Jun 13
2025
|
Darcy Antonellis |
BUY
Grant, award, or other acquisition
|
Direct |
4,200
+7.06%
|
-
|
Jun 13
2025
|
Enrique Senior |
BUY
Grant, award, or other acquisition
|
Direct |
4,200
+5.98%
|
-
|
Jun 13
2025
|
Kevin Leroy Mitchell |
BUY
Grant, award, or other acquisition
|
Direct |
4,200
+17.77%
|
-
|
Jun 13
2025
|
Wanda Marie Gierhart Chief Marketing & Content Ofc |
SELL
Open market or private sale
|
Direct |
52,524
-35.63%
|
$1,628,244
$31.85 P/Share
|
May 27
2025
|
Valmir Fernandes Pr - Cinemark International |
SELL
Open market or private sale
|
Direct |
25,000
-16.07%
|
$825,000
$33.01 P/Share
|
May 15
2025
|
Melissa Thomas EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,200
-3.3%
|
$223,200
$31.43 P/Share
|
Feb 28
2025
|
Melissa Thomas EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,200
-3.19%
|
$180,000
$25.59 P/Share
|
Feb 25
2025
|
Wanda Marie Gierhart Chief Marketing & Content Ofc |
SELL
Open market or private sale
|
Direct |
9,119
-5.83%
|
$246,213
$27.0 P/Share
|
Feb 25
2025
|
Michael Cavalier EVP-General Counsel |
SELL
Bona fide gift
|
Direct |
246,581
-82.27%
|
-
|
Feb 23
2025
|
Wanda Marie Gierhart Chief Marketing & Content Ofc |
SELL
Payment of exercise price or tax liability
|
Direct |
22,719
-6.42%
|
$613,413
$27.45 P/Share
|
Feb 23
2025
|
Valmir Fernandes Pr - Cinemark International |
SELL
Payment of exercise price or tax liability
|
Direct |
23,268
-6.59%
|
$628,236
$27.45 P/Share
|
Feb 23
2025
|
Sean Gamble Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
101,530
-7.47%
|
$2,741,310
$27.45 P/Share
|
Feb 23
2025
|
Melissa Thomas EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
27,626
-5.52%
|
$745,902
$27.45 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 209K shares |
---|
Payment of exercise price or tax liability | 342K shares |
---|---|
Bona fide gift | 451K shares |
Open market or private sale | 406K shares |